US Medical Innovations Raises $10.2 M in Private Placement

TAKOMA PARK, Md.–(BUSINESS WIRE)–#USMI—US Medical Innovations, LLC (USMI), a subsidiary of US Patent Innovations, LLC, announced today it has secured a $10.2 million private placement deal from multiple sources including existing partners and new investors. USMI will be using these funds to ramp-up manufacturing of its newly-released Canady Plasma® XL-1000 SMART Electrosurgical Generator (XL-1000) and … [Read more…]

Africa Wound Biologics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Africa Wound Biologics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2028” report has been added to ResearchAndMarkets.com’s offering. The regional research report on Africa wound biologics market is a customer intelligence and competitive study of the Africa market. Moreover, the report provides deep insights into demand forecasts, market trends, and, … [Read more…]

Wolters Kluwer Names Chris Sullivan Vice President Commercial Segment for Clinical Effectiveness

WALTHAM, Mass.–(BUSINESS WIRE)–Wolters Kluwer, Health today announced that Christopher Sullivan has been appointed as Vice President and General Manager of the Commercial Segment for Clinical Effectiveness. In his 11 years at Wolters Kluwer, Sullivan has held a range of leadership positions in strategy, product management, pricing, and strategic partnerships. Most recently he served as Vice … [Read more…]

New Mental Wellness Platform Frankly Aims to Bridge Gap in Support for Adults in Texas

Frankly offers personalized Core Journey through yearly membership with support provided by board-certified medical providers, licensed therapists and certified Care Guides AUSTIN, Texas–(BUSINESS WIRE)–Frankly, the online holistic mental wellness provider, today announced its therapeutic platform is now available for adults in Texas, to provide the right mix of tools and treatments for mental health and … [Read more…]

SimplePractice Appoints Ian Knox as Chief Product Officer

Knox’s extensive experience brings practice management solutions for health and wellness practitioners to the next level LOS ANGELES–(BUSINESS WIRE)–SimplePractice, an EngageSmart solution and industry-leading platform simplifying the health and wellness experience, announced the appointment of Ian Knox as Chief Product Officer. Knox brings over 20 years of product leadership experience to SimplePractice. He has worked … [Read more…]

LivaNova to Announce Third-Quarter 2022 Results

LONDON–(BUSINESS WIRE)–#advancedcirculatorysupport–LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its third-quarter 2022 results on Wednesday, November 2, 2022, at 12 p.m. London time (8 a.m. EDT). The Company will release its third-quarter 2022 results prior to the call. A live audiocast will be accessible at … [Read more…]

INNOVO® Leverages Powerful New Creative and a More Effective Approach to TV Advertising to Help Revolutionize Women’s Health

Leading FemTech Brand Partners with Quirk Creative and Simulmedia to Drive Audience Awareness and Online Sales Through Targeted Premium Video NEW YORK–(BUSINESS WIRE)–#simulmedia–Although one in three women experience Stress Urinary Incontinence (SUI) at some point in their lives, public and media taboos around the topic have exacerbated the physical and mental stress caused by bladder … [Read more…]

Insights on the Opioid Induced Constipation Drugs Global Market to 2030 – Featuring AstraZeneca, Daiichi Sankyo, Pfizer and Salix Pharmaceuticals Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Opioid Induced Constipation Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030” report has been added to ResearchAndMarkets.com’s offering. The global opioid induced constipation drugs market is rising at a significant pace, projected to rise at a CAGR of 4.7% during the … [Read more…]

Clovis Oncology and Isotopia Announce Lutetium-177 Clinical Supply Agreement

Isotopia to supply its medical radioisotope, lutetium-177, for the clinical development of Clovis Oncology’s targeted radionuclide therapy candidate FAP-2286 BOULDER, Colo. & PETACH TIKVA, Israel–(BUSINESS WIRE)–$CLVS—Clovis Oncology, Inc. (NASDAQ: CLVS) and Isotopia Molecular Imaging Ltd. today announced the signing of a clinical supply agreement that provides Clovis Oncology with Isotopia’s lutetium-177 (177Lu) n.c.a. for use … [Read more…]

Nucleai and Propath UK announce partnership for end-to-end AI-powered spatial analysis of a 30-plex immunofluorescence immuno-oncology panel

Combining the power of spatial biology and AI, Propath and Nucleai push the boundaries of pathology tissue analytics to develop a novel, high multiplexed immunofluorescence (IF) panel and associated AI-powered algorithm for biomarker discovery and development HEREFORD, United Kingdom & TEL AVIV, Israel–(BUSINESS WIRE)–#aipowered—Propath UK, Europe’s leading CRO for spatial biology, and Nucleai, a leader … [Read more…]